Solimene Franscesco, Maggio Ruggero, De Sanctis Valerio, Escande William, Malacrida Maurizio, Stabile Giuseppe, Zakine Cyril, Champ-Rigot Laure, Anselmino Matteo, Ferraro Anna, Mantica Massimo, Zucchelli Giulio, Dell'Era Gabriele, Mascia Giuseppe, Ricci Maga Renata, Pandozi Claudio, Rossi Pietro, Scaglione Marco, Zingarini Gianluca, Garnier Fabien, Loricchio Maria Luisa, Pelargonio Gemma, Lepillier Antoine
Department of Cardiac Electrophysiology and Arrhythmology, Clinica Montevergine, Mercogliano, Italy.
Department of Biomedical Sciences and Public Health, Marche Polytechnic University, Ancona, Italy.
J Interv Card Electrophysiol. 2024 Dec;67(9):2137-2146. doi: 10.1007/s10840-024-01849-0. Epub 2024 Jul 8.
The combination of highly localized impedance (LI) and contact force (CF) may improve tissue characterization and lesion prediction during radiofrequency (RF) pulmonary vein isolation (PVI) in patients with atrial fibrillation (AF).
We report the outcomes of our acute and long-term clinical evaluation of CF-LI-guided PVI in consecutive AF ablation cases from an international multicenter clinical setting.
Three hundred twenty-four consecutive patients from 20 European centers undergoing RF catheter ablation with the Stablepoint™ catheter were enrolled in the CHARISMA registry. Of these, 275 had a minimum follow-up of 1 year and were included in the primary analysis.
The mean procedure duration was 115 ± 47 min, and the mean fluoroscopy time was 9.9 ± 6 min. At the end of the procedures, all PVs had been successfully isolated in all study patients. Minor complications were reported in 12 patients (4.4%). At 1 year, 36 (13.1%) patients had had an AF recurrence, and freedom from antiarrhythmic drugs and AF recurrence was achieved in 228 (82.9%) patients. The recurrence rate was higher in patients with persistent AF (21/116, 18.1%) than in those with paroxysmal AF (15/159, 9.4%; p = 0.0459). On multivariate logistic analysis adjusted for baseline confounders, only time > 6 months from first diagnosis of AF to ablation (HR = 2.93, 95%CI 1.03 to 8.36, p = 0.0459) was independently associated with recurrences.
An ablation strategy for PVI guided by CF-LI technology proved safe and effective and resulted in a low recurrence rate of AF over 1-year follow-up, irrespective of the underlying AF type.
Catheter Ablation of Arrhythmias with a High-Density Mapping System in Real-World Practice. (CHARISMA). URL: http://clinicaltrials.gov/ Identifier: NCT03793998.
在心房颤动(AF)患者的射频(RF)肺静脉隔离(PVI)过程中,高度局部化阻抗(LI)和接触力(CF)的联合应用可能会改善组织特征描述和病变预测。
我们报告了在国际多中心临床环境中,对连续房颤消融病例进行CF-LI引导下PVI的急性和长期临床评估结果。
来自20个欧洲中心的324例连续接受使用Stablepoint™导管进行RF导管消融的患者被纳入CHARISMA注册研究。其中,275例患者至少随访1年,并纳入主要分析。
平均手术时间为115±47分钟,平均透视时间为9.9±6分钟。手术结束时,所有研究患者的所有肺静脉均成功隔离。12例患者(4.4%)报告有轻微并发症。1年时,36例(13.1%)患者发生房颤复发,228例(82.9%)患者实现了无抗心律失常药物和无房颤复发。持续性房颤患者的复发率(21/116,18.1%)高于阵发性房颤患者(15/159,9.4%;p = 0.0459)。在对基线混杂因素进行调整的多因素逻辑分析中,只有从首次诊断房颤到消融的时间>6个月(HR = 2.93,95%CI 1.03至8.36,p = 0.0459)与复发独立相关。
CF-LI技术引导下的PVI消融策略被证明是安全有效的,并且在1年的随访中房颤复发率较低,无论潜在的房颤类型如何。
现实世界实践中使用高密度标测系统进行心律失常的导管消融。(CHARISMA)。网址:http://clinicaltrials.gov/ 标识符:NCT03793998。